Suvretta Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
Suvretta Capital Management's IONS Position: Q3 2026 in Review
Suvretta Capital Management held its Ionis Pharmaceuticals (IONS) position steady in Q3 2026 at 10,800 shares worth $482K. The position accounts for 0.01% of the portfolio, ranked #86.
Suvretta Capital Management first reported a position in IONS in Q1 2024 and has held it in 11 quarters since. The position peaked at $856K in Q2 2026. 465 funds tracked by Wall St. Rank hold IONS as of Q3 2026.
- Suvretta Capital Management held 10,800 shares of Ionis Pharmaceuticals worth $482K as of Q3 2026.
- Suvretta Capital Management left its Ionis Pharmaceuticals share count unchanged in Q3 2026.
- Ionis Pharmaceuticals made up 0.01% of Suvretta Capital Management's portfolio in Q3 2026, its #86 holding.
- Suvretta Capital Management first reported a position in Ionis Pharmaceuticals in Q1 2024 and has held it in 11 quarters since.
- Suvretta Capital Management's Ionis Pharmaceuticals position peaked at $856K in Q2 2026.
- 465 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.
Based on Suvretta Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.